Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.European Heart Journal|June 2, 2025
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosisChristian Nitsche, Stephan Dobner, Hannah R Rosenblum, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Tissue characterization in cardiac amyloidosis: a joint consensus document by the gruppo di studio di cardiopatologia (SIAPEC) and the SIC/ANMCO Italian cardiac amyloidosis network (RIAC)Giuseppe Vergaro, Carla Giordano, Angela Pucci, et al.Journal of the American Heart Association|November 12, 2025
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin CardiomyopathyAlberto Aimo, Martina Nesti, Giuseppe Vergaro, et al.European Heart Journal|March 22, 2023
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, et al.European Heart Journal. Quality of Care & Clinical Outcomes|May 20, 2025
Change in prevalence of ATTR variants in Italy - Results from a National SurveyCarlo Fumagalli, Simone Longhi, Alberto Aimo, et al.Journal of Neurology|February 15, 2025
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational studyVincenzo Di Stefano, Pietro Guaraldi, Angela Romano, et al.Frontiers in Neurology|September 15, 2025
Monitoring patients and asymptomatic carriers with hereditary transthyretin amyloidosis: regional protocol of Emilia-Romagna ATTR working groupPietro Guaraldi, Isabella Allegri, Alessandra Ariatti, et al.European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.Pageof 7